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1. Introduction 
Diabetes mellitus complicating pregnancy is one of the most common antenatal complications 
that are associated with significant perinatal mortality and morbidity (Magee et al., 1993; Platt 
et al., 2002; Schmidt et al., 2001). Diabetic pregnancies can be divided into two categories: those 
with pre-gestational or pre-existing diabetes mellitus in which the diagnosis is made in the 
pre-pregnancy state, and those with gestational diabetes mellitus (GDM). Pre-existing diabetes 
consists of type I (insulin-dependent) diabetes mellitus (IDDM)with an incidence of around 
0.5%, and type 2 ( non-insulin-dependent) diabetes with an incidence of 2-3% ( Kapoor et al., 
2007). The incidence of gestational diabetes mellitus differs in different populations (Gunton et 
al., 2001) and ethnic groups, and was shown to be as high as 13% in Chinese populations (Ko 
et al., 2002). Effective treatment of pre-existing as well as gestational diabetes mellitus was 
shown to improve outcome and reduce perinatal mortality, as compared to untreated patients 
(Lao et al., 2001; Langer et al., 2005).   
The pathological conditions encountered in fetuses of diabetic pregnancies differ in those 
with pre-existing diabetes mellitus and those with gestational diabetes. Pre-existing 
diabetics with persistent hyperglycaemia in the perinatal period are at higher risks of 
congenital malformations (Reece et al., 2007). In addition, those women with long-standing 
pre-existing diabetes before the index pregnancy run a higher risk of having diabetic 
vasculopathy that may affect various organ-systems in the body. Involvement of the uterine 
arteries will affect the development of an effective utero-placenta blood flow, which would 
be vital in maintaining normal growth and development in the fetus. The clinical 
manifestation of fetal growth restriction (also called intrauterine growth restriction) is thus 
more common in these pregnancies. The presence of significant congenital abnormalities 
and severe fetal growth restriction resulting from such conditions are logically directly 
related to increase in perinatal mortality and morbidity. On the other hand,  gestational 
diabetes is usually only diagnosable either in a screening protocol or from clinical risk 
factors, by oral glucose tolerance test from mid trimester onwards, due to the effects of 
diabetogenic hormones from the placenta. The carbohydrate intolerance is thus short-lived 
and should last only from mid trimester to term. The hyperglycaemic states of the diabetes 
should revert to normal shortly after delivery with the removal of the placenta.  Thus, 
chronic complications such as vasculopathy in the pregnant women will not have time to 
evolve during the course of pregnancy. On the contrary, the diabetic hyperglycaemic states 
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in gestational diabetes would stimulate fetal hyperinsulinemia, which would in turn lead to 
over-secretion of insulin-like growth factors (IGF), leading to overgrowth of the fetus 
(Kapoor et al., 2007). Thus, in contrast to pre-gestational diabetes mellitus, where 
vasculopathy is rife and the incidences of pre-eclampsia and fetal growth restriction are 
commonly encountered, GDM pregnancies pose a different category of pathophysiology 
and clinical risks. The most common fetal problems for gestational diabetes will be 
macrosomia with associated polyhydramnios, as well as increased risks of near term 
stillbirths and neonatal metabolic complications in livebirths (Sacks, 2007). Indeed, recent 
data borne out by the HAPO study has demonstrated that in maternal hyperglycaemic 
states less severe than in diabetes mellitus is also associated with increased risks of adverse 
pregnancy outcomes (HAPO Study Cooperative Research Group, 2008)  
A lot of emphasis has been put on fetal surveillance in these high-risk pregnancies in the 
attempt to optimise pregnancy outcome. There is, however, no consensus as to the best 
methods of antepartum surveillance (American College of Obstetricians & Gynecologists, 
2001). The use of Doppler studies of the umbilical artery has been demonstrated to reduce 
perinatal adverse outcome in non-diabetic pregnancies (Alfirevic et al., 1995), but its use in 
diabetic pregnancies have shown conflicting results. While umbilical artery Doppler studies 
have been shown to be more predictive of adverse outcome than cardiotocography and 
biophysical profile in diabetic pregnancies (Bracero et al., 1996), fetal compromise would 
occasionally still be observed despite normal Doppler studies (Johnstone et al., 1992). Thus, 
the precise value of Doppler studies in the monitoring of GDM pregnancies remains 
controversial.  
2. Serial growth scans for diabetic pregnancies 
The recommendations for diagnosis and treatment of GDM of the Fifth International 
Workshop-Conference on Gestational Diabetes Mellitus (Metzger et al., 2007) suggest 
consideration of fetal growth patterns to guide metabolic management of pregnant women 
with GDM. However, estimation of fetal weight, particularly at term and in fetuses with 
high neonatal weight, is not as precise as desirable (Sacks et al, 2000). Fetal overgrowth and 
accelerated growth velocity of the abdominal circumference in the third trimester is known 
to predict large for gestational age babies (Kehl et al., 1996).  Fetal overgrowth with 
macrosomia and associated polyhydramnios is associated with higher risks of near term 
stillbirth, as well as various neonatal metabolic derangements, including neonatal 
hypoglycaemia, electrolyte disturbances and neonatal jaundice. Previous randomized 
studies have demonstrated that measurement of fetal abdominal circumference throughout 
pregnancy in women with GDM is useful to identify pregnancies at high risk for fetal 
overgrowth and thus in need of more vigilant treatment including insulin therapy (Bonomo 
et al., 2004).  
Serial measurements of the fetal abdominal circumference have been used to guide 
metabolic management of pregnancies complicated by gestational diabetes mellitus. There is 
at present no consensus as to the optimal protocol for such growth scans. A recent study 
evaluated the number of sonograms needed to reliably predict the absence of fetal 
overgrowth in GDM pregnancies.  A total of 4478 ultrasound examinations were performed 
on 1914 subjects. Of 518 women with fetal abdominal circumference > 90th percentile, the 
diagnosis was detected in 73.9% with the first ultrasound examination at entry and in 13.1% 
with the second ultrasound examination. Of the fetuses, 85.9 and 86.9% of the fetuses were 
www.intechopen.com
 
Applications of Doppler Studies for Fetal Surveillance in Diabetic Pregnancies 
 
265 
born non-large- for- gestational- age when abdominal circumference was < 90th percentile at 
24-27 weeks and 28-32 weeks respectively; and 88% were born non-large-for-gestational-age 
when both scans showed normal growth. For those women who had no risk factors for fetal 
overgrowth, such as body mass index > 30 kg/m2, history of macrosomia, and fasting 
glucose > 100 mg/dl, the accuracy of prediction of a non-large-for-gestational-age neonate 
was 90.0, 89.5 and 95.2%. The predictive ability did not increase with more than two normal 
scans. It was concluded that the yield of sonographic diagnosis of a large fetus dropped 
markedly after the finding if a large fetal abdominal circumference < 90th percentile on tow 
sonograms, which excludes with a high reliability the risk of a large for gestational age 
newborn. The ability was enhanced in women who had no risk factors for neonatal 
macrosomia (Schaefer-Graf et al., 2011). Thus, sonographic evaluation of fetal growth 
parameters is a crucial part of ultrasound assessment of diabetic pregnancies. The 
application of Doppler examination should take into account the data from such growth 
assessment parameters.  
3. Use of Doppler studies for fetal surveillance 
Various Doppler parameters have conventionally been utilized for fetal surveillance. The 
use maternal uterine artery Doppler as a screening tool to predict subsequent development 
of pre-eclampsia and fetal growth restriction in later gestation have gained acceptance in 
recent years. Umbilical artery Doppler, middle cerebral artery Doppler, or the combination 
of the two to produce a cerebral-placental ratio, have been widely used for the assessment of 
growth restricted fetuses. Less commonly used arterial Doppler parameters include fetal 
thoracic aorta or renal arteries. Venous Doppler assessment has been extensively 
investigated in recent years, including umbilical venous waveforms, intrahepatic venous 
Doppler and ductus venosus Doppler. The following sections attempt to review the 
application of the more commonly used Doppler parameters in diabetic pregnancies.  
3.1 Maternal uterine artery 
Maternal uterine artery remodelling is the hallmark sign of successful placentation, which 
can be demonstrated by progressive alterations in Doppler waveforms derived from the 
immediate extrauterine portion of the uterine artery. Pre-pregnancy uterine arteries show 
high resistance and elastic recoil in the form of early diastolic notches and low diastolic flow 
(Schulman et al., 1986). Successful placental invasion removes intimal muscle and reduces 
vascular resistance and elastic properties, giving more rigorous diastolic flow. In 
pregnancies with normal placentation, Doppler studies show that this remodelling is rapid, 
with loss of notching by 12 weeks and low resistance indices by 20 weeks or sooner. When 
placentation is deficient, notching of waveforms remains with high resistance 
(Papageorhiou et al., 2001). Such a picture of deficient placentation strongly predicts 
maternal hypertension, including proteinuric pre-eclampsia, fetal growth restriction and 
fetal demise (Coleman et al., 2000). Uterine artery Doppler screening using high resistance, 
persistent notching, or both, identifies such risks with a sensitivity up to 85% for severe 
proteinuric pre-eclampsia and for severe fetal growth restriction (Papageorghiou et al., 
2002). However, there is so far no well established evidence of using such screening for 
adverse outcomes for either pre-existing or gestational diabetes mellitus alone.  
When uterine artery Doppler were examined in a cohort of 43 pregnancies complicated by 
insulin-dependent diabetes, it was found that the uterine artery resistance indices were 
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slightly higher in the presence of evident morphological vasculopathy, but could not predict 
diabetic specific fetal morbidity. It was concluded that in patients with diabetic 
vasculopathy, the uterine artery was also affected, but there was no relationship with long 
or short term parameters of glycaemic control. Based on the data, it was concluded that 
Doppler flow velocimetry of the uterine artery was a poor predictor of diabetes-specific fetal 
morbidity (Zimmermann et al., 1994).  
In another prospective survey, 24 well controlled insulin dependent pregestational diabetic 
pregnancies were compared with 25 healthy pregnant women and Doppler ultrasound was 
performed on two occasions in the third trimester separated by a one-month interval. At the 
first examination, the median pulsatility index in the fetal thoracic aorta and in the uterine 
artery was significantly lower in the diabetic group as compared to healthy controls, 
whereas umbilical and uterine pulsatility indices were similar. At the second examination at 
a more advanced gestation, a significant physiological decrease in the median pulsatility 
index of the fetal aorta and uterine artery was observed in the controls, but not in the 
diabetic group. There was no correlation between the glycosylated haemoglobin or random 
blood glucose levels and the Doppler indices. An increased incidence of neonatal morbidity 
was noted in the diabetic group. Thus, the normal physiological third trimester fall in 
resistance indices in the uteroplacental and fetal placental indices was apparently absent in 
the diabetic group, and this was associated with increased neonatal morbidity. The 
pulsatility indices were not influenced by blood glucose regulation (Grunewald et al., 1996).  
A similar retrospective study of 155 pre-gestational diabetic women between 22 weeks 
gestation and term also found that abnormal uterine artery Doppler with increased 
pulsatility index was related to pre-existing diabetic states with vasculopathy and adverse 
pregnancy outcome. There was an increased incidence of abnormal umbilical artery Doppler 
in those with abnormal uterine artery Doppler, indicating that the vasculopathy might 
influence placental perfusion and fetal well-being (Pietryga et al., 2006). Therefore, it is 
logical to expect that such screening by uterine artery Doppler will likely be effective only if 
the diabetic pregnancy is also complicated by gestational hypertension or fetal growth 
restriction. Given the higher incidence of such obstetric complications in pre-existing 
diabetes mellitus as compared to GDM, screening of diabetic pregnancies using uterine 
artery Doppler in mid trimester would probably produce a higher yield in the former group.  
3.2 Fetal umbilical artery Doppler  
The use of Doppler studies of the umbilical artery has been demonstrated to reduce 
perinatal adverse outcome in non-diabetic pregnancies (Alfirevic et al.,1995), but its use in 
diabetic pregnancies have shown conflicting results. Umbilical artery angle independent 
indices (systolic/diastolic ratio or pulsatility index) decrease with advancing gestation 
because of decreases in placenta vascular resistance, which physiologically occurs with 
advancing gestation. In pathologic conditions, such as intrauterine/ fetal growth restriction, 
the umbilical artery waveform change and the angle-independent indices become abnormal, 
giving values above their reference ranges. End-diastolic velocity may thus change from 
normal to reduced, absent or reversed. These changes represent an increased placental 
vascular resistance, and could pathologically be associated with a decrease in the number of 
placental arteries per high power field (Giles et al., 1985). The most common scenario for 
fetal growth restriction include placental insufficiency in singleton or multiple pregnancies 
from various aetiologies, which may or may not be associated with pre-eclampsia or other 
maternal conditions, or in fetuses with congenital malformations. Such a picture commonly 
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occurs in women with pre-existing diabetes mellitus with vasculopathy. In pregnancies with 
suspected fetal growth restriction, the use of umbilical artery Doppler has been 
demonstrated to reduce the number of perinatal deaths and unnecessary obstetric 
interventions. In the context of diabetic pregnancies, however, the applications of umbilical 
artery Doppler remain controversial.  
To investigate the vascular resistance by Doppler ultrasound in the umbilical artery of 53 
IDDM pregnancies longitudinally over the course of pregnancy, the resistance index of the 
Doppler waveform was correlated with the mean value of a 24 hour blood glucose profile 
and the concentrations of glycosylated haemoglobin (HbA1C), which represented 
parameters of metabolic control. Regression analysis, however, showed no significant 
correlation between vascular resistance and mean blood glucose levels or HbA1C 
concentrations (Zimmermann et al., 1992).  
In another study that included 67 normotensive women with pregnancies complicated by 
IDDM, the umbilical artery pulsatility index was compared with both pregnancy 
complications and perinatal outcome. The last umbilical pulsatility index value before 
delivery was used for analysis, and Doppler results were not used for patient management. 
Out of this cohort, 44 (66%) had pulsatility index values within the normal range between 
the 5th to 95th percentile, while 23 (34%) had abnormally high pulsatility index values. 
Among the group with pathologically abnormal umbilical pulsatility indices, analysis of the 
data revealed a significantly higher incidence of both caesarean section for acute fetal 
distress and perinatal complications. These complications include respiratory distress 
syndrome, hyperbilirubinemia, neonatal hypoglycaemia, and the need for neonatal 
intensive care unit admission. The authors concluded that in at least one third of IDDM 
patients, increased vascular resistance in the umbilical arteries were found, and these also 
suffered from higher incidences of perinatal complications (Fadda et al., 2001). 
A retrospective study of 146 patients with gestational diabetes noted that Doppler examination 
of the umbilical arteries seemed to be of little clinical value unless pregnancy was complicated 
by pre-eclampsia or intrauterine growth restriction. The study included 227 patients with 
diabetes, and umbilical artery Doppler velocimetry and glycaemic control were examined in 
the third trimester. An elevated systolic/diastolic ratio and an abnormal glycosylated 
haemoglobin level were associated with adverse pregnancy outcome, but there was no 
stratification for vascular disease or fetal growth restriction in the data (Bracero et al., 1996).  
In a prospective study of 65 well controlled diabetic pregnancies, Doppler measurements of 
uterine arteries, umbilical artery, the fetal descending thoracic aorta, and the middle cerebral 
artery (MCA) were performed together with cordocentesis for measurement of umbilical 
venous blood pH, pO2 and haematocrit. It was found that the mean umbilical venous blood 
pH was significantly lower and the haematocrit significantly higher than the appropriate 
normal mean for gestation for these diabetic pregnancies. However, the Doppler indices of 
the placental and fetal circulations were essentially normal, except in some of the cases 
complicated by pre-eclampsia or intrauterine growth restriction (Salvesen et al., 1993). It 
was thus concluded that maternal diabetes mellitus was not associated with abnormalities 
in Doppler indices of the placental or fetal circulations.  
To evaluate a random single Doppler study of the systolic/diastolic ratio of the umbilical 
artery as a predictor of perinatal outcome in diabetic pregnancies, a prospective double-
blind study was performed in 92 diabetic pregnancies between 28 and 40 weeks gestation, 
and the results were associated with perinatal outcome parameters. The sensitivity and 
specificity of the Doppler studies as a predictor of poor perinatal outcome were 39% and 
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92% respectively. The positive and negative predictive values were 54% and 86% 
respectively. The authors suggested that the systolic/diastolic ratio of the umbilical artery 
offer no advantage over other well established tests in management of diabetic pregnancies 
(Ben-Ami et al., 1995).  
In a cohort of 104 women with both type I and type II pre-existing diabetes mellitus, 
umbilical artery Doppler was performed at 28, 32, 36 and 38 weeks gestation. Overall, 22% 
had an elevated pulsatility index. If the Doppler examination was carried out within 2 
weeks of delivery, 71% with abnormal umbilical artery Doppler had adverse perinatal 
outcome (likelihood ratio 4.2). However, the sensitivity of umbilical artery Doppler to 
predict such adverse outcome was only 35%, while specificity was 94%. The positive 
Predictive value was 80% and negative predictive value was 68%. Only 30% of women with 
adverse perinatal outcome had abnormal umbilical artery Doppler measurements. The 
authors thus concluded that the performance of umbilical artery Doppler was not 
satisfactory even in this group of high risk women with pre-existing diabetes, and that it 
was not a good predictor of adverse perinatal outcome (Wong et al., 2003).  
To investigate whether complications were higher in diabetic pregnancies with cardiac 
maladaptation, fetal, uteroplacental and echocardiographic examinations were compared in 
the second and third trimester between diabetic and healthy pregnant women. Physiological 
cardiac hypertrophy was found in healthy women but was less prominent in patients with 
diabetes. While the majority of patients studied have normal Doppler results, the abnormal 
uteroplacental flow group consisted entirely of women with pregestational diabetes, 
especially IDDM patients. Neonatal complications were also more common in this 
subgroup. No relationship was found between echocardiographic findings, Doppler 
waveforms and perinatal outcome. Similar to previous studies, the findings confirmed that 
umbilical and uteroplacental Doppler were useful only in pre-existing diabetes, but not in 
GDM patients (Parlakgumus et al., 2010).  
From the above studies, it can be seen that both observational data and randomized control 
data have failed to show any consistent association between maternal diabetes and 
abnormal umbilical artery Doppler indices. It is apparent that the current evidence supports 
the use of umbilical artery Doppler only in those patients with diabetes who have 
pregnancies complicated by hypertensive diseases, fetal growth restriction, or vasculopathy. 
Umbilical Doppler studies cannot be recommended as a routine screening for fetal 
surveillance especially in patients without pre-existing diabetes mellitus (Pietryga et al., 
2006). 
3.3 Middle cerebral artery Doppler  
The middle cerebral artery (MCA) is the most studied cerebral artery because it is simple to 
sample, consistent and reproducible, and provides information on the cerebral blood flow in 
normal and growth restricted fetuses (Mari et al., 2008). In addition, the MCA can be 
sampled at an angle of near zero degrees between the ultrasound beam and the direction of 
the blood flow, so that the genuine velocity of the blood flow can be measured. In growth 
restricted foetuses, there is a redistribution of the blood flow from the fetal periphery to the 
brain, commonly known as the brain-sparing effect. In severe fetal growth restriction with 
abnormal umbilical artery, MCA Doppler is a valuable adjunct, with abnormal findings 
signifying the onset of compromise that should soon require delivery (Dubiel et al, 
2002).Overt MCA changes appear as increased diastolic velocity, and an altered cerebral-
placental ratio will thus be observed. Changes in cerebral-placental ratio may be at least 
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partly pressure-dependent, reflecting structural placental deficiencies, whereas brain-
sparing is attributed to hypoxia induced cerebrovascular dilatation (Baschat, 2003).  In those 
pregnancies over 34 weeks gestation, placental functional decline may be more dominant 
that structural decline. Thus MCA changes in brain-sparing may appear in small fetuses 
with near-normal umbilical artery Doppler (Severi et al., 2002; To et al., 2005). Such findings 
are again more likely to occur in women with pre-existing diabetes mellitus with 
vasculopathy than in those with gestational diabetes mellitus.  
Another use for examining the MCA is to detect fetal anaemia. The MCA can be insonated 
at an angle between zero and 15 degrees to measure the actual flow velocity in the vessel. 
The lowest intra- and inter-observer variability is obtained when the MCA proximal to the 
transducer is sampled near its origin from the internal carotid artery without the use of 
angle correction using a 1-2 mm sample volume (Mari et al., 2005). A peak systolic velocity 
(PSV) of 1.50 MoM in fetuses at risk of anaemia has a sensitivity for detecting anaemia of up 
to 100% (confidence interval 86-100%) in red cell alloimmunization as well as other cases of 
anaemia (Mari et al., 2000). In the context of diabetic pregnancies, maternal hyperglycemia is 
thought to cause an increase in fetal haematocrit, as cordocentesis has demonstrated a 
positive relationship between maternal hyperglycaemia and fetal polycythemia (Salvesen et 
al., 1992). Theoretically, the increase in blood viscosity due to polycythemia might be 
reflected by a corresponding decrease in blood flow velocity in the fetal circulation, which is 
opposite to the fetal anaemia model. This would be particularly prominent in affected 
macrosomic fetuses in gestational diabetes, who often suffer prolonged neonatal jaundice 
resulting from the polycythemia. However, such findings have not been consistently 
demonstrated in published reports.  
In a prospective study of 138 singleton pregnancies with GDM, umbilical artery pulsatility 
index and middle cerebral artery pulsatility index were measured serially every 4 weeks 
from the diagnosis of GDM until delivery. A total of 305 Doppler examinations were 
performed with one to four examinations for each woman. About 27% ( 38) had one or more 
abnormal pregnancy outcomes: placental abruption, pre-eclampsia, preterm delivery, small-
for-gestational-age, low Apgar scores, neonatal jaundice requiring treatment, sepsis, birth 
trauma, meconium aspiration syndrome, respiratory and neurological complications, 
However, there was extensive overlapping of the umbilical artery and MCA pulsatility 
indices,  as well as MCA PSV values between those with normal and abnormal pregnancy 
outcomes. It was thus concluded that that Doppler studies of the umbilical and cerebral 
vessels were not useful for predicting outcome in these GDM pregnancies (Leung et al., 
2004).  In another cohort of 84 GDM pregnancies, it was found that stratifying the fetuses 
into appropriate, small- and large-for-gestational-age did not give any better correlation 
between the umbilical or middle cerebral impedance indices, but did apparently show that 
the bigger fetuses had lower MCA PSV and higher mean umbilical venous flow velocity 
than the smaller fetuses (To et al, 2009). It has been proposed that the pathophysiological 
basis of altered placental vascular flow patterns in diabetic pregnancies was functional, 
related to hyperglycemia induced thromboxane/ prostacyclin ratio imbalance (Saldeen et 
al., 2002), rather than to structural abnormalities related to trophoblastic invasion during 
development of the placental vascular bed. Thus, the abnormal umbilical waveforms and 
abnormal placental-cerebral Doppler ratios that were observable in non-diabetic 
pregnancies with fetal growth restriction would not be applicable to gestational diabetic 
pregnancies without significant growth restriction. The observation of lower MCA PSV in 
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the larger or macrosomic fetuses might be compatible with this hypothesis. In short, in the 
absence of pre-eclampsia or significant fetal growth abnormalities, the use MCA Doppler in 
diabetic pregnancies appears to have limited value.  
3.4 Umbilical Vein waveform and umbilical venous flow volume  
Arterial waveforms describe downstream resistance in critical vascular beds, in which 
disease or response to pathological conditions causes blood flow alterations. Venous 
Doppler, however, provides important cardiac data about stressed fetal circulations.  
Potential targets include the umbilical vein, inferior vena cava and the ductus venosus, 
while regional networks such as the hepatic, superior vena cava, intracranial and 
pulmonary veins have not provided clinically relevant cardiac indicators (Harman et al., 
2003). By mid second trimester, the fetal umbilical vein normally has a continuous blood 
flow pattern, but this pattern can become pulsatile in pathological conditions, such as in 
significant fetal growth restriction and in hydropic fetuses. Thus, for umbilical venous 
waveforms, it has been advocated that a qualitative assessment of continuous versus 
pulsatile blood flow is used (Mari et al., 2008). Such venous pulsations most likely represent 
severe and critical fetal myocardial dysfunction and usually only appear at very late stages 
of fetal compromise. Umbilical venous waveforms are therefore not useful as an early sign 
for assessment of fetal well being for timing delivery. 
The use of umbilical venous volume flow based on calculations of the cross-sectional area of 
the umbilical vein has been used and reported in previous studies to have a high degree of 
reproducibility (Boito et al., 2003). There have been suggestions for using the intra-
abdominal portion of the umbilical vein (Haugen et al., 2004), as the latter would be less 
mobile than a free cord loop. Empirical experience showed that the demand on technical 
expertise between the two sites were largely similar, though  the variations in the diameter 
of the intra-hepatic umbilical vein along its length could be somewhat higher than that of 
the free cord loop, and calculations of its cross-sectional diameter more complicated. In 
addition, since routine umbilical arterial Doppler would be performed on a free cord loop, it 
would be practical and convenient to extend the measurements to the adjacent vein within 
the cord segment (To & Mok, 2009). 
To evaluate whether umbilical and middle cerebral arterial Doppler indices and umbilical 
venous volume flow are reflective of maternal gestational diabetic states, and whether such 
indices would be associated with the size of the fetus, a prospective observational study was 
performed in a cohort of 84 GDM pregnancies and compared with 62 non-diabetic controls. 
It was found that the mean pulsatility index values for the umbilical artery and the mean 
total umbilical venous flow (TUVF) and TUVF per unit birth weight did not differ 
significantly between diabetic and non-diabetic pregnancies. Large-for-gestational-age 
fetuses showed higher TUVF than normal size fetuses, but the TUVF per unit birth weight 
was higher for small-gestational-age fetuses. These differences were independent of their 
diabetic status. The only significant differences between non-diabetic and diabetic 
pregnancies in the data appeared to be the difference in the diameter and the mean flow 
volume of the umbilical vein, which were again probably more likely to be related to the 
size of the fetus. It was thus concluded that umbilical venous Doppler measurements near 
term were unable to distinguish between diabetic and non-diabetic pregnancies, and that 
umbilical venous flow volume was apparently more sensitive to the size of the fetus than to 
the maternal diabetic state (To & Mok, 2009). As fetal size variations could be secondary to 
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poor maternal glycemic control, and macrosomic fetuses would demonstrate such 
measurements, it might be argued that the total umbilical venous flow would still indirectly 
reflect fetal conditions, or the presence or absence of macrosomia. However, it is obvious 
that direct measurement of fetal growth parameters would be more precise in defining fetal 
overgrowth. 
The mean total umbilical venous flow has been shown in previous studies to be related to 
the total cardiac output of the fetus, so that the larger fetus with a higher cardiac output 
would have higher flow volumes (Boito et al., 2003). It was not surprising that when 
controlled for birthweight, the mean total umbilical venous flow differences between large- 
and small-for-gestational-age fetuses were greatly attenuated. Recent data have shown that 
in growth restricted fetuses, there would be a preferential distribution of umbilical venous 
flow to the ductus venosus rather than via the fetal liver (Bellotti et al, 2004). However, 
whether such venous shunting mechanisms would be responsible for the observed higher 
mean umbilical venous flow per unit weight in small-for –gestational-age fetuses as 
compared to larger ones would require further evaluation. In diabetic pregnancies, on the 
other hand, it has been found that fetal liver volume could be associated with accelerated 
growth in these fetuses, though only marginal differences could be shown in the umbilical 
venous volume flow. Further studies to compare growth and TUVF volumes in fetuses 
within a large non-diabetic population would be of value to study the differences in 
circulatory volumes in relation to size of the fetus. 
3.5 Artioventricular valves 
The atrioventricular values (mitral and tricuspid) are characterized by two peaks – the “E” 
wave corresponding to the rapid filling of the ventricles and the “A” wave that corresponds 
to the atrial contraction. The “A” wave is taller than the “E” wave, and may reflect the 
stiffness of the fetal cardiac chambers. With advancing gestation, the E/A wave ratio 
increases. By contrast, after birth, the “E” wave will be taller than the “A” wave. In growth 
restricted fetuses, the two waves become abnormal (the E/A ratio increases) and in severe 
cases, there will be tricuspid and mitral regurgitation (Rizzo et al., 1988). Thus, in the study 
of diabetic pregnancies, such studies would be of value only if the pregnancy is complicated 
by severe fetal growth restriction.  
3.6 Ductus venosus Doppler waveforms 
The ductus venosus provides a unique combination of data, as it is the primary regulator of 
venous return in both normal and abnormal fetuses and is also a direct conduit of right 
atrial retrograde pulse waves (Harman et al., 2003). The ductus waveform is responsive to 
changes in oxygenation independent of cardiac function, and it is readily imaged because of 
its very high focal velocity on colour Doppler from early second trimester onwards. Ductus 
venosus waveforms are characterized by two peaks, the S and D, followed by a nadir, the 
atrial wave. Haemodynamically, these phases reflect the rapid chronologic change in 
pressure gradients between the umbilical vein and the right atrium. In normally grown 
fetuses, there is forward flow at the ductus venosus, and the pulsatility index for veins (S-
D/a) decreases with advancing gestation. In growth restricted fetuses, the pulsatility index 
increases, and in the most severe cases, there will be reverse flow in the atrial wave.  
Ductus venosus waveform deterioration precedes and predicts changes in biophysical 
profile score that indicate need for delivery (Baschat et al., 2003). This deterioration is 
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hypothesised to be the result of a volume/pressure effect, in which excess afterload is 
transmitted through the heart, and myocardial dysfunction appears as an end-stage 
compromise. A second indication of ductus venosus Doppler occurs at 12-14 weeks in 
conjunction with nuchal translucency screening and uterine artery screening. Abnormal 
retrograde atrial waves are a strong predictor of fetal cardiac abnormality, and also a good 
predictor of Down syndrome (Bilardo et al., 2001). Given the higher risks of congenital 
cardiac abnormalities in pregnancies complicated by pre-existing diabetes mellitus, ductus 
venosus screening at this gestation may have a role. There is as yet, scanty data in the 
literature that describe the use of ductus Doppler specific to diabetic pregnancies, and the 
application of ductus Doppler largely refers to that of growth restricted fetuses in general. 
To evaluate the ability of the ductus venosus Doppler to predict adverse perinatal outcome 
in pregnancies complicated by pre-existing diabetes mellitus, a prospective study that 
included 82 women with pre-existing diabetes mellitus was performed. The ductus venosus 
Doppler index was defined as abnormal if the ductus venosus peak velocity index for veins 
was equal to or greater than the 95th percentile for gestation. Abnormal ductus venosus 
index was identified in 30.5% (n=25).  Adverse perinatal outcome was identified in around 
one-third of these with abnormal indices (8/25) compared to 12.3% (5/57) with a normal 
ductus index. The sensitivity of the ductus venosus index in predicting adverse perinatal 
outcome in pre-existing diabetic pregnancies was thus 53.3% and specificity was 74.5%, with 
a positive predictive value of 32% and negative predictive value of 87.7%. The authors 
concluded that it should be useful to include ductus venosus Doppler indices as part of 
antenatal screening of pregnancies complicated by pre-existing diabetes mellitus (Wong et 
al., 2010).  
4. Practical application of Doppler studies to diabetic pregnancies 
It has thus been postulated that the degree of glycemic control would have more impact on 
the Doppler study results rather than directly related to the diabetic state (Bracero et al., 
1991). The lack of association of Doppler parameters to maternal diabetic state was 
particularly true when the pregnancy was not complicated by fetal growth restriction or 
pre-eclampsia. While higher incidences of adverse outcome in diabetic pregnancies were 
related to the occurrence of such complications or to poor glycemic control with 
macrosomia, Doppler studies have apparently only limited effectiveness in predicting 
adverse perinatal outcome in these fetuses. Summing up the available data from the 
literature, a basic protocol for the sequential use of Doppler studies in both pre-existing and 
gestational diabetic pregnancies can be proposed (Table 1). Nevertheless, the clinical 
effectiveness of such a protocol still remains to be evaluated.  
5. Summary 
Available randomized control data and observational data have failed to demonstrate any 
consistent association between maternal diabetes and abnormal umbilical arterial Doppler 
indices. Doppler measurements of other fetal vessels apart from the umbilical arteries, such 
as the fetal descending aorta and the middle cerebral artery resistance indexes, or the peak 
systolic velocity of the middle cerebral arteries have also been studied in GDM pregnancies, 
and a similar lack of predictability for adverse outcome was generally found.  The lack of 
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Gestation 
(weeks) 
Vessel 
Doppler 
parameters 
Primary endpoint 
PDM or 
GDM 
12 DV 
Retrograde atrial 
waves 
aneuploidy; 
congenital cardiac 
abnormalities 
 
P/GDM  
 Uterine  Notching, PI FGR PGD 
22-24 Uterine  Notching, PI FGR PGD 
 UA, MCA PI, CPR FGR PGD 
3rd 
trimester 
UA, MCA 
UV 
AV valves 
DV 
PI, CRP, PSV  
PI, TUVF 
AV flow, TR, MR 
Retrograde atrial 
valves  
FGR 
PGD/ 
GDM 
PDM: pre-existing diabetes mellitus, GDM: gestational diabetes mellitus, DV: ductus venosus 
PI: pulsatility index, CRP: cerebral placental ratio, FGR: fetal growth restriction, 
PSV: peak systolic velocity, AV: atrioventricular, TR: tricuspid regurgitation, MR: mitral regurgitation 
Table 1. Sequential Doppler applications foe diabetic pregnancies 
association of Doppler parameters to maternal diabetic state was particularly true when the 
pregnancy was not complicated by fetal growth restriction or pre-eclampsia. While higher 
incidences of adverse outcome in diabetic pregnancies were related to the occurrence of 
poor glycemic control with macrosomia and polyhydramnios, conventional arterial Doppler 
indexes and cerebral /placental Doppler ratios have not been shown to be effective in 
picking up these high risk fetuses. The use of umbilical venous Doppler and venous volume 
flow based on calculations of the cross-sectional area of the umbilical vein has been reported 
in various studies to have a high degree of reproducibility. Venous volume flow 
measurements have not been found to be consistently reflective of maternal gestational 
diabetic states. Such volume flow measurements apparently reflected well the fetal growth 
and size and thus indirectly the glycemic control and the risks of perinatal complications. 
Doppler studies of other venous sites, including the intraabdominal/ intrahepatic portion of 
the umbilical vein, or the ductus venosus have also been studied with variable results. 
Whether such measurements could be used directly for monitoring fetal well being requires 
further evaluation. 
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